EyePoint Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 696K | 620K | 966K | 5.3M | 24.5M | 11.6M | 10.5M | 9.5M |
| Cost of Goods Sold | 528K | 375K | 721K | 165K | 805K | 816K | 736K | 1.4M |
| Gross Profit | 168K | 245K | 245K | 5.2M | 23.6M | 10.8M | 9.8M | 8.1M |
| R&D Expenses | 72.1M | 59.2M | 47.8M | 55.5M | 58.6M | 43.4M | 29.5M | 29.8M |
| Operating Expenses | 87.4M | 70.6M | 62.3M | 67.4M | 72.5M | 56.0M | 42.5M | 42.6M |
| Operating Income | -87.2M | -70.3M | -62.0M | -62.2M | -48.8M | -45.2M | -32.7M | -34.5M |
| Other Income / Gains | 2.3M | 2.9M | 2.3M | 2.9M | 3.6M | 3.9M | 3.4M | 3.7M |
| Net Income | -84.8M | -67.6M | -59.7M | -59.4M | -45.2M | -41.4M | -29.4M | -30.8M |
| EPS (Diluted) | -0.99 | -0.81 | -0.85 | -0.85 | -0.65 | -0.64 | -0.54 | -0.58 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.241 | 0.395 | 0.254 | 0.969 | 0.967 | 0.93 | 0.93 | 0.852 |
| General And Administrative Expenses | 15.2M | 11.4M | 14.5M | 11.9M | 13.9M | 12.6M | 13.0M | 12.8M |
| Selling And Marketing Expenses | 3K | -6K | 26K | 35K | 35K | 51K | 24K | 50K |
| Selling General And Administrative Expenses | 15.2M | 11.4M | 14.5M | 11.9M | 13.9M | 12.6M | 13.0M | 12.8M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 87.9M | 71.0M | 63.0M | 67.6M | 73.3M | 56.8M | 43.3M | 44.0M |
| Interest Income | 2.3M | 2.9M | 2.3M | 2.9M | 3.6M | 3.9M | 3.4M | 3.7M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 14K | 0 | 0 |
| Depreciation And Amortization | 636K | 698K | 576K | 538K | 497K | 467K | 408K | 362K |
| Ebitda | -84.2M | -57.9M | -59.2M | -58.8M | -44.7M | -40.8M | -29.0M | -30.5M |
| Ebitdaratio | -121.043 | -93.327 | -61.238 | -11.025 | -1.828 | -3.523 | -2.751 | -3.215 |
| Operating Income Ratio | -125.325 | -113.46 | -64.208 | -11.668 | -1.997 | -3.904 | -3.112 | -3.645 |
| Income Before Tax | -84.9M | -67.4M | -59.7M | -59.3M | -45.2M | -41.3M | -29.4M | -30.8M |
| Income Before Tax Ratio | -121.957 | -108.747 | -61.834 | -11.126 | -1.848 | -3.565 | -2.79 | -3.253 |
| Income Tax Expense | 50K | -186K | 0 | 93K | 0 | 90K | 0 | 0 |
| Net Income Ratio | -121.885 | -109.047 | -61.834 | -11.143 | -1.848 | -3.573 | -2.79 | -3.253 |
| Epsdiluted | -0.99 | -0.81 | -0.85 | -0.85 | -0.65 | -0.64 | -0.54 | -0.58 |
| Weighted Average Shs Out | 86.0M | 83.0M | 70.2M | 69.9M | 69.8M | 64.6M | 54.4M | 53.2M |
| Weighted Average Shs Out Dil | 86.0M | 83.0M | 70.2M | 69.9M | 69.8M | 64.6M | 54.4M | 53.2M |